T Cell Exhaustion.


Journal

Annual review of immunology
ISSN: 1545-3278
Titre abrégé: Annu Rev Immunol
Pays: United States
ID NLM: 8309206

Informations de publication

Date de publication:
02 Jan 2024
Historique:
medline: 3 1 2024
pubmed: 3 1 2024
entrez: 2 1 2024
Statut: aheadofprint

Résumé

T cell responses must be balanced to ensure adequate protection against malignant transformation and an array of pathogens while also limiting damage to healthy cells and preventing autoimmunity. T cell exhaustion serves as a regulatory mechanism to limit the activity and effector function of T cells undergoing chronic antigen stimulation. Exhausted T cells exhibit poor proliferative potential; high inhibitory receptor expression; altered transcriptome, epigenome, and metabolism; and, most importantly, reduced effector function. While exhaustion helps to restrain damage caused by aberrant T cells in settings of autoimmune disease, it also limits the ability of cells to respond against persistent infection and cancer, leading to disease progression. Here we review the process of T cell exhaustion, detailing the key characteristics and drivers as well as highlighting our current understanding of the underlying transcriptional and epigenetic programming. We also discuss how exhaustion can be targeted to enhance T cell functionality in cancer. Expected final online publication date for the

Identifiants

pubmed: 38166256
doi: 10.1146/annurev-immunol-090222-110914
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Andrew Baessler (A)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; email: dvignali@pitt.edu.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.

Dario A A Vignali (DAA)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; email: dvignali@pitt.edu.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.

Classifications MeSH